Boehringer Ingelheim Pharmaceuticals

pill_clock.jpgAuthored by Kyle Petersen

On July 12, 2011, a federal district court in the Southern District of Florida jumped into the divide over whether pharmaceutical representatives are exempt from the FLSA’s overtime requirements.  In Palacios v. Boehringer Ingelheim Pharmaceuticals, Inc., the court granted summary judgment in favor of the plaintiff, holding that she was not properly classified as exempt

Continue Reading Pharmaceutical Representatives as Exempt? Contrary to the 3rd and 9th Circuits, a Florida District Court Enters the Fray